Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
AMIDOTRIZOATO DE SODIO Y AMIDOTRIZOATO DE MEGLUMINA IBEROINVESA PHARMA 370 mg/ml SOLUCION ORAL Y RECTAL EFG
Solution
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- AMIDOTRIZOATO SODIO — 100 mg
- AMIDOTRIZOATO MEGLUMINA — 660 mg
- Pharmaceutical form Home Med Cabinet grouping
- Solution
- Availability in Spain
- No packs currently marketed
Packs
AMIDOTRIZOATO DE SODIO Y AMIDOTRIZOATO DE MEGLUMINA IBEROINVESA PHARMA 370 mg/ml SOLUCION ORAL Y RECTAL EFG, 1 frasco de 100 ml
100 ml
National code
Not marketed687667Strength of this pack 100 mg
AMIDOTRIZOATO DE SODIO Y AMIDOTRIZOATO DE MEGLUMINA IBEROINVESA PHARMA 370 mg/ml SOLUCION ORAL Y RECTAL EFG, 10 frascos de 100 ml
1000 ml
National code
Not marketed687668Strength of this pack 100 mg
AMIDOTRIZOATO DE SODIO Y AMIDOTRIZOATO DE MEGLUMINA IBEROINVESA PHARMA 370 mg/ml SOLUCION ORAL Y RECTAL EFG, 20 frascos de 100 ml
2000 ml
National code
Not marketed687669Strength of this pack 100 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 75426Official data
- Marketing authorisation holder
- IBEROINVESA PHARMA S.L.Official data
- Authorised
- Feb 8, 2012Official data
- Authority form code
- 53Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.